Atea Pharmaceuticals Inc (AVIR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.89 +0.02 (+0.70%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.89 unch (unch) 16:02 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -168,385 | -135,956 | -115,909 | 121,190 | -10,947 |
| Depreciation Amortization | -11,405 | -15,030 | -5,205 | 29 | 19 |
| Accounts receivable | N/A | N/A | N/A | N/A | -5,815 |
| Accounts payable and accrued liabilities | 206 | 1,701 | -1,983 | 10,289 | -488 |
| Other Working Capital | -7,476 | 16,163 | -46,586 | -247,845 | 300,205 |
| Other Operating Activity | 51,561 | 47,727 | 48,701 | 29,332 | 13,760 |
| Operating Cash Flow | $-135,499 | $-85,395 | $-120,982 | $-87,005 | $296,734 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 56,105 | 40,303 | -453,467 | N/A | N/A |
| PPE Investments | N/A | N/A | -1,943 | -4 | -26 |
| Investing Cash Flow | $56,105 | $40,303 | $-455,410 | $-4 | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 267 | 257 | 370 | 1,465 | 317,632 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 214,116 |
| Financing Cash Flow | $267 | $257 | $370 | $1,465 | $531,748 |
| Beginning Cash Position | 143,823 | 188,658 | 764,680 | 850,224 | 21,768 |
| End Cash Position | 64,696 | 143,823 | 188,658 | 764,680 | 850,224 |
| Net Cash Flow | $-79,127 | $-44,835 | $-576,022 | $-85,544 | $828,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,499 | -85,395 | -120,982 | -87,005 | 296,734 |
| Capital Expenditure | N/A | N/A | -1,943 | -4 | -26 |
| Free Cash Flow | -135,499 | -85,395 | -122,925 | -87,009 | 296,708 |